IL1A antibody (AA 113-271)
Quick Overview for IL1A antibody (AA 113-271) (ABIN7870149)
Target
See all IL1A AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 113-271
-
Purpose
- IL1A Antibody / IL1 alpha (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 113-271 from the human protein was used as the immunogen for the IL1A antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the IL1A antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the IL1A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- IL1A (Interleukin 1 alpha (IL1A))
-
Alternative Name
- IL1A
-
Background
- Two forms of interleukin-1, designated IL-1 alpha and beta, have been described. Although encoded by distinct genes and exhibiting roughly only 25 % sequence identity, IL-1a and IL-1b bind to the same receptor and seem to elicit similar biological responses. IL-1 production is generally thought to be associated with inflammation, but it has also been shown to be expressed during kidney development, thymocyte differentiation and cartilage degradation. IL-1 plays a critical role in the regulation of immune response and inflammation, acting as an activator of T and B lymphocytes and natural killer (NK) cells. In T cells, IL-1 stimulates the production of IL-2 and selectively inhibits IL-4 expression. IL-1 induces B cell proliferation and maturation, and immunoglobulin synthesis. NK cells require IL-1 for production of the anti-pathogen IFN-. IL-1 has also been implicated in several pathological conditions including rheumatoid arthritis, inflammatory bowel disease and atherosclerosis.
-
UniProt
- P01583
-
Pathways
- NF-kappaB Signaling, Autophagy, Cancer Immune Checkpoints
Target
-